| 1 |
夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017) [J].中国骨质疏松杂志, 2019, 25(03): 281-309.
|
| 2 |
Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, et al. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? [J]. Osteoporosis International, 2020, 31(12): 2271-2286.
|
| 3 |
Wang S, Zhang S, Wang S, et al. A comprehensive review on Pueraria: Insights on its chemistry and medicinal value [J]. Biomed Pharmacother, 2020, 131: 110734.
|
| 4 |
Yang X, Zheng H, Liu Y, et al. Puerarin for OVX-Induced postmenopausal osteoporosis in murine model:systematic review and Meta-Analysis [J]. Curr Stem Cell Res Ther, 2020, 15(1): 37-42.
|
| 5 |
吕遐,扶琼.原发性骨质疏松症的研究进展与最新指南解读[J].临床内科杂志, 2020, 37(05): 319-322.
|
| 6 |
Marcus R. Post-menopausal osteoporosis [J]. Best Pract Res Clin Obstet Gynaecol, 2002, 16(3): 309-327.
|
| 7 |
Langdahl B, Ferrari S, Dempster DW. Bone modeling and remodeling:potential as therapeutic targets for the treatment of osteoporosis [J]. Ther Adv Musculoskelet Dis, 2016, 8(6): 225-235.
|
| 8 |
Yang H, Bullock WA, Myhal A, et al. Cancellous bone May have a greater adaptive strain threshold than cortical bone [J]. JBMR Plus, 2021, 5(5): e10489.
|
| 9 |
Clynes MA, Harvey NC, Curtis EM, et al. The epidemiology of osteoporosis [J]. Br Med Bull, 2020, 133(1): 105-117.
|
| 10 |
Hamada T, Matsubara H, Hikichi T, et al. Rat model of an autologous cancellous bone graft [J]. Sci Rep, 2021, 11(1): 18001.
|
| 11 |
Yin X, Wang X, Hu X, et al. ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways [J]. Exp Cell Res, 2015, 335(1): 107-114.
|
| 12 |
Liu G, Lu Y, Mai Z, et al. Suppressing MicroRNA-30b by Estrogen Promotes Osteogenesis in Bone Marrow Mesenchymal Stem Cells [J]. Stem cells international, 2019, 2019: 7547506.
|
| 13 |
Li J, PENG Y. Effect of puerarin on osteogenic differentiation of human periodontal ligament stem cells [J]. The Journal of international medical research, 2020, 48(4): 300060519851641.
|
| 14 |
刘永红,陈远明,周昊楠,等.葛根素诱导脂肪干细胞成骨分化的实验研究[J].中国骨质疏松杂志, 2020, 26(05): 631-635.
|
| 15 |
Tiyasatkulkovit W, Charoenphandhu N, Wongdee K, et al. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica [J]. Phytomedicine, 2012, 19(13): 1147-1155.
|
| 16 |
Yasuda H. Discovery of the RANKL/RANK/OPG system [J]. J Bone Miner Metab, 2021, 39(1): 2-11.
|
| 17 |
Xiao L, Zhong M, Huang Y, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways [J]. Aging, 2020, 12(21): 21706-21729.
|
| 18 |
Suthon S, Jaroenporn S, Charoenphandhu N, et al. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats [J]. J Nat Med, 2016, 70(2): 225-233.
|
| 19 |
Lamy O, Stoll D, Aubry-Rozier B, et al. Stopping denosumab [J]. Curr Osteoporos Rep, 2019, 17(1): 8-15.
|
| 20 |
Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects [J]. Phytotherapy research: PTR, 2014, 28(7): 961-975.
|
| 21 |
Li B, Wang Y, Gong S, et al. Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics [J]. Phytomedicine, 2022, 102: 154198.
|